| Net Cash Provided by (Used in) Operating Activities |
$19,132,000 |
USD |
-49% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$146,277,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$7,548,000 |
USD |
-98% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
302,500,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
78,306,713 |
shares |
-3.2% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$172,957,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$94,459,000 |
USD |
-58% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$42,188,000 |
USD |
-22% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Depreciation |
$7,600,000 |
USD |
65% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$67,025,000 |
USD |
-4.3% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$1,736,184,000 |
USD |
0.4% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$259,253,000 |
USD |
24% |
Q1 2024 |
Q1 2024 |